Physician

John M Kailath, M.D.

According to 2025 Medicare claims, John Kailath, M.D. (NPI: 1619943313) practices hematology/oncology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is SIERRA HEMATOLOGY AND ONCOLOGY MEDICAL CENTERS (NPI: 1992796759; TIN: 680305843) and primary practice location at 95608-0302. Kailath is affiliated with the Vivant Health ACO (ACO ID: A5068), participating under the MSSP model.

Kailath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 446 traditional Medicare patients, billed 113,947 HCPCS/CPT codes, and received $1,722,897 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 876 prescription claims across 158 beneficiaries totaling $3,533,273 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 69 claims. Open Payments data shows 44 records totaling $1,186. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,383,008 and ending at $1,722,897. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,038,824 to $3,533,273. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,125 to $1,428.